Clinical trial shows JAK inhibitor improves multiple autoimmune conditions in patients with Down syn…

A new study published in eLIFE by researchers from the Linda Crnic Institute for Down Syndrome (Crnic Institute) at the University of Colorado Anschutz Medical Campus reports the initial results of a first-in-kind clinical trial testing the safety and efficacy of a JAK inhibitor to decrease the…

Click here to view the original article.